PCCB ∆19/∆481
MUSCSDi001-A-2
General
iPSC Line |
|
| hPSCreg name | MUSCSDi001-A-2 |
| Cite as: | MUSCSDi001-A-2 (RRID:CVCL_ZX60) |
| Alternative name(s) |
PCCB ∆19/∆481
|
| iPSC line type | Human induced pluripotent stem cell (hiPSC) |
| Similar iPSC lines |
MUSCSDi001-A-1 (PCCB ∆14/∆29) MUSCSDi001-A (iPSK3) |
| Last update | 29th September 2020 |
| User feedback | |
Provider |
|
| Generator |
Steve's Duncan Lab (MUSCSD)
Contact:
Steve's Duncan Lab (MUSCSD) |
External iPSC Databases |
|
| BioSamples | SAMEA7023717 |
| Cellosaurus | CVCL_ZX60 |
| Wikidata | Q102114569 |
General iPSC Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
iPSC Genetic Modification
| Disease/phenotype related modifications |
|
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
46,XY
Karyotyping method:
G-Banding
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA7023731 |
Ethics
Also have a look at the ethics information for the parental line
MUSCSDi001-A
.
| Is there an MTA available for the cell line? | No |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
iPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
MUSCSDi001-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
| Genes | |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
iPSC Culture Conditions
| Surface coating | eCadherin | ||||||
| Feeder cells |
No |
||||||
| Passage method |
Enzyme-free cell dissociation
EDTA
|
||||||
| O2 Concentration | 4 % | ||||||
| CO2 Concentration | 5 % | ||||||
| Medium |
mTeSR™ 1
Supplements
|
||||||
| Has Rock inhibitor (Y27632) been used at passage previously with this iPSC line? | No |
||||||
| Has Rock inhibitor (Y27632) been used at cryo previously with this iPSC line? | Yes |
||||||
| Has Rock inhibitor (Y27632) been used at thaw previously with this iPSC line? | Yes |
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| POU5F1 (OCT-4) |
Yes |
|
|
|||
| SOX2 |
Yes |
|
||||
| NANOG |
Yes |
|
Score:
| Marker | Present | Absent |
| mCpG | ||
| OCT4 |
Differentiation Potency
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46,XY,add(9)(q21.2)[11]/46,XY,add(9)(q21.2),dup(20)(q11.2q11.2)[9]
Karyotyping method:
G-Banding
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.